Atyr Pharma Inc [NASDAQ: ATYR] closed the trading session at $5.39.
The stocks have a year to date performance of 48.90 percent and weekly performance of 39.28 percent. The stock has been moved at 56.69 percent over the last six months. The stock has performed 49.72 percent around the most recent 30 days and changed 77.89 percent over the most recent 3-months.
If compared to the average trading volume of 1.50M shares, ATYR reached to a volume of 5803885 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Atyr Pharma Inc [ATYR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ATYR shares is $18.55 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ATYR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Atyr Pharma Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 18, 2025. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on January 06, 2025, representing the official price target for Atyr Pharma Inc stock. Previously, the target price had yet another raise to $17, while Wells Fargo analysts kept a Overweight rating on ATYR stock.
The Average True Range (ATR) for Atyr Pharma Inc is set at 0.36 The Price to Book ratio for the last quarter was 6.39, with the Price to Cash per share for the same quarter was set at 0.86.
ATYR stock trade performance evaluation
Atyr Pharma Inc [ATYR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 39.28. With this latest performance, ATYR shares gained by 49.72% in over the last four-week period, additionally plugging by 56.69% over the last 6 months – not to mention a rise of 206.25% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ATYR stock in for the last two-week period is set at 82.89, with the RSI for the last a single of trading hit 90.13, and the three-weeks RSI is set at 76.41 for Atyr Pharma Inc [ATYR]. The present Moving Average for the last 50 days of trading for this stock 3.38, while it was recorded at 4.61 for the last single week of trading, and 3.10 for the last 200 days.
Atyr Pharma Inc [ATYR]: An insightful look at the core fundamentals
Atyr Pharma Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.79 and a Current Ratio set at 7.79.
